Microsoft word - gousse_cv__aua_[1][2]

1. Date Revised:

PERSONAL

2. Name:
ANGELO E. GOUSSE, M.D.

3. Home Phone:
(786) 200-3447 (C)
4. Office Phone:

5. Home Address:

Office Address:

Email Address:

6. Current Academic Rank:

7. Primary Department:
Department of Urology University of Miami School of Medicine 8. Secondary or Joint
Department of Obstetrics & Gynecology Appointments:
9. Citizenship:

10. Visa Type:

HIGHER EDUCATION

11. Institutional:
Yale University School of Medicine: M.D. May 29, 1990 York College City University of New York: B.S. June, 1986 12. Non-Institutional:

13. Certification & Licensure:

• Diplomate of the American Board of Urology • Florida Medical License (ME 0069645) • California Medical License (G083830) • Drug Enforcement Agency Certification • Certification, Licensure: Advanced Trauma

EXPERIENCE

14. Academic:

• Tenured Professor of Urology: Department of Urology 2008- present University of Miami Miller School of Medicine • Associate Professor of Urology: Department • Assistant Program Director: Urology Residency • Clinical Instructor: Female Urology, University of California Los Angeles (UCLA) • Fellow in Female Urology, Urodynamics & • Fellow: Reconstructive Urology & Urodynamics • Chief Resident: Baylor College of Medicine, • Resident: Baylor College of Medicine, Urology • National Medical Fellowship at Yale University • Biomedical Research Support Program Minority York College City University of New York 15. Hospital Appointments:

• Staff Urologist for Spinal Cord Injury Section • Jackson Memorial Hospital, Miami, Florida • Cedars Medical Center, Miami, Florida • Veterans Affairs Medical Center, Miami, Florida • Sylvester Comprehensive Cancer Center/ University of Miami Hospital & Clinics,
16. Military: None

PUBLICATIONS
17. Books and Monographs:
Urology and the Primary Care Practitioner Mosby-Wolfe, Medical Communications, 1997 Chapter: Voiding Dysfunction in Multiple Sclerosis Textbook of Neurogenic Bladder - Adults and Children Medicine, OB/GYN, Psychiatry, and Surgery eMedicine Journal, May 2002, Volume 3 (5) 4- Angelo E. Gousse and Robert R. Kester Chapter (48) :Urethral , Scrotal, and Penile Surgery Complications in Surgery and Trauma Informa Healthcare , USA , Inc, 2007 5- Hari S.G.R. Tunuguntla and Angelo E. Gousse Chapter (15) Voiding Dysfunction After Pelvic Surgery Female Urology ( 3 rd Edition ) Saunders Elsevier, 2008 6- Gousse AE and Leboeuf L.and Brian Cohen Chapter: Voiding Dysfunction in Multiple Sclerosis Textbook of Neurogenic Bladder - Adults and Children
18. Recent Juried or Refereed Journal Articles:
1.Caruso D, Gousse AE. The challenges of iatrogenic proximal ureteric
reconstruction. Curr Urol Rep. 2009 Nov;10(6):409-12
2.Cohen BL, Caruso DJ, Kanagarajah P, Gousse AE. Predictors of response to
intradetrusor botulinum toxin-A injections in patients with idiopathic overactive
bladder. Adv Urol. 2009:328364. Epub 2009 Sep 8
3.Caruso DJ, Gomez CS, Gousse AE. Medical management of stress urinary
incontinence: is there a future? Curr Urol Rep. 2009 Sep;10(5):401-7. Review.
4.Caruso D, Gousse AE. Urinary incontinence and pneumaturia: management and
treatment. Curr Urol Rep. 2009 Sep;10(5):326-30
5.Caruso D, Gousse AE. Urethrovaginal fistula repair. Curr Urol Rep. 2009
Sep;10(5):321-5
6. Cohen BL, Barboglio P, Rodriguez D, Gousse AE. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn. 2009;28(3):205-8. 7. Alexander MS, Biering-Sorensen F, Bodner D, Brackett NL, Cardenas D, Charlifue S, Creasey G, Dietz V, Ditunno J, Donovan W, Elliott SL, Estores I, Graves DE, Green B, Gousse A, Jackson AB, Kennelly M, Karlsson AK, Krassioukov A, Krogh K, Linsenmeyer T, Marino R, Mathias CJ, Perkash I, Sheel AW, Shilero G, Schurch B, Sonksen J, Stiens S, Wecht J, Wuermser LA, Wyndaele JJ.International standards to document remaining autonomic function after spinal cord injury. Spinal Cord. 2009 Jan;47(1):36-43. Epub 2008 Oct 28. Review. 8. Cooke TJ, Gousse AE. A historical perspective on cystocele repair--from honey to pessaries to anterior colporrhaphy: lessons from the past. J Urol. 2008 Jun;179(6):2126-30. Epub 2008 Apr 18. 9. Cohen BL, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. .J Sex Med. 2008 Jun;5(6):1418-23. Epub 2008 Mar 19. 10. Unwala DJ, Barboglio P, Gousse AE.Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution? Curr Urol Rep. 2007 Sep;8(5):419-24. Review. 11. Cohen BL, Gousse AE. Current techniques for vesicovaginal fistula repair: surgical pearls to optimize cure rate.Curr Urol Rep. 2007 Sep;8(5):413-8. Review. 12. Bent AE Gousse, A, Hendrix, Klutke, Monga, et al. Duloxetine compared with placebo for the treatment: Neurourology and Urodynamics of women with mixed urinary incontinence. Neurourol Urodyn. 2008;27(3):212-21. 13.Rivera R, Barboglio PG, Hellinger M Gousse AE. Staging rectourinary fistulas to guide treatment. J Urol.2007 Feb; 177(2); 586-8. 14.Cohen BL, Rivera R, Barboglio P, Gousse A. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-a injection J Urol 2007 Mar 177(3):1006-10; 15.Bent AE, Gousse AE, Hendrix SL, Klutke CG, Monga AK, Yuen CK, Meadows ES, Yalcin I, Muram D; Duloxetine Mixed Urinary Incontinence Study Group. World J Urol. 2006 Sep;23(4):231-5. Epub Review. 16.Rivara R, Gousse A. Dose postmenopausal hormone therapy cause urinary incontinence? Nat Clin Pract Urol.2006 Jun; 3(6);304-5. 17.Cohen BL, Tunguntla HS, Gousse A. Predictors of success for first stage neuromodulation: motor verse sensory response. J Urol.2006 Jun;175(6):2178-80; discussion 2180-1. 18.Bent AE, Gousse AE, Hendrix SL, Klutke CG, Monga AK, Yuen CK, Meadows ES, Yalcin I, Muram D. Duloxetine Mixed Urinary Incontinence Study Group.Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence. Obstet Gynecol.2005 Oct;106(4):767-73. 19.Tunuguntla HS, Manoharan M, Gousse AE. Managementof neobladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review World J Urol. 2005 Sep;23(4):231-5. 20.Lokeshwar VB, Selzer MG, Cerwinka WH, Gomez MF, Kester RR, Bejany DE, Gousse AE. Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity. J Urol. 2005 Jul;174(1):344-9. 21.Gousse AE, Tunuguntla HS, Leboeuf L. Two-stage management of severe postprostatectomy bladder neck contracture associated with stress incontinence. Urology. February 2005. 22.Tunuguntla HS, Gousse AE. Female sexual dysfunction following vaginal surgery: myth or reality? Curr Urol Rep. 2004 Oct; 5(5):403-11. 23.Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade 4 cystocele repair using four-defect repair and porcine xenograft acellular matrix (Pelvicol): outcome measures using SEAPI. Urology. 2004 Aug; 64(2):282-6. 24.Tunuguntla HS, Gousse AE. Missed bilateral bladder perforation during pubovaginal sling procedure. J Urol. 2004 Jul; 172(1):189-90. PMID: 15201769 25.Leboeuf L, Mendez LE, Gousse AE. Small bowel obstruction associated with tension-free vaginal tape.Urology. 2004 Jun; 63(6):1182-4. 26.Riveros S, Lavernia C, Tunguntla HS, Gousse AE. Intractable chronic pelvic pain relieved after bone anchor removal. J Urol. 2004 Mar; 171(3):1242-3. PMID: 27.Gousse A, Lorenzo-Gomez MF, Lebouef L. [Female urethral diverticulum. Report of a case] Actas Urol Esp. 2003 Nov-Dec; 27(10):814-21. 28.Leboeuf L, Tellez C, Ead D, Gousse AE. Complication of bowel perforation during insertion of tension-free vaginal tape. J Urol. October 2003; 170 (4): 1310; discussion 1310-1. 29.Kester RK, Mooppan UMM, Gousse AE, Alver JE, Gintautas J, Gulmi FA, Abadir AR, Kim H. Pharmacological characterization of isolated human prostate. J Urol. September 2003; 170 (3): 1032-8. 30.Kester RR, Leboeuf L, Jorda M, Gousse AE. Trichouria caused by ovarian teratoma with carcinoid elements. J Urol. August 2003; 170 (2): 520. 31.Kester RR, Leboeuf L, Amendola M, Kim S, Benoit A, Gousse AE. Value of express T2-weighted pelvic MRI in the preoperative evaluation of severe pelvic floor prolapse: a prospective study. Urology. June 2003; 61: 1135-1139. 32.Razdan S, Leboeuf L, Meinbach DS, Weinstein D, Gousse AE. Current practice patterns in the urologic surveillance and management of spinal cord injured patients. Urology. May 2003; 61(5): 893-6. 33.Gousse AE, Meinbach DS, Kester RR, Razdan S, Kim SS, Pareek K, Leboeuf L, Weinstein DA, Sipski M. Renal ultrasound correlates with renal nuclear scan in upper tract surveillance of spinal cord injured patients. Topic in Spinal Cord Injury Rehabilitation 8(3)/2003: 1-7. 34.Sipski M, Alexander C, Guo X, Gousse A, Zlamal R. Cardiovascular effects of sildenafil in men with SCIs at and above T6. Topic in Spinal Cord Injury Rehabilitation 8(3)/2003: 26-34. 35.Gousse AE, Lambert M, Kester R. Oral pharmacotherapy to manage erectile dysfunction in spinal cord-injured men. Topic in Spinal Cord Injury Rehabilitation, 8(1)/2002: 51-62. 36.Madjar S, Gousse A.E. Postirradiation vesicovaginal fistula completely resolved with conservative treatment. Urogynecol J Pelvic Floor Dysfunct. 2001; 12(6):405-6. 37.Gousse AE, Pareek K, Lavernia CJ, Kava B. Omental interposition for repair of a vesico-acetabular fistula. J Urol. December 2001; 166(6): 2313. 38.Gousse AE, Madjar S, Lambert M, Fishman IJ. Artificial urinary sphincter for the treatment of post radical prostatectomy urinary incontinence: long-term subjective results. J Urol. November 2001; 166(5): 1755-8. 39.Madjar S, Raz S, Gousse AE. Fixed and dynamic urethral compression in the treatment of post prostatectomy urinary incontinence – Is history repeating itself? J Urol. August 2001; 166 (2): 411-5. 40.Madjar S, Gousse AE. Post-irradiation vesicovaginal fistula completely resolved with conservative treatment. International Urogynecology Journal. July 2001; 12 (4): 405-6. 41.Evans D, Madjar S, Politano VA, Bejany DE, Lynne CM, Gousse AE. Interposition flaps in transabdominal vesicovaginal fistula repairs: Are they really necessary? Urology. April 2001; 57(4): 670-674. 42.Tiguert R, Ravery V, Madjar S, Gousse AE. [Acute urinary retention secondary to clear cell adenocarcinoma of the urethra] published in French. Progrès en Urologie. February 2001; 11 (1): 70-72. 43.Madjar S, Evans D, Duncan RC, Gousse AE. Collaboration and practice patterns among urologists and gynecologists in the treatment of urinary incontinence and pelvic floor prolapse: A survey of the International Continence Society Members. Neurourology and Urodynamics. 2001; 20(1): 3-11. 44.Gousse AE, Barbaric ZL, Safir MH, Madjar S, Marumoto AK, Raz S. Dynamic half fourier acquisition, single shot turbo spin-echo magnetic resonance imaging for evaluating the female pelvis. J Urol. November 2000; 164(5): 1606-1613. 45.Gousse AE, Safir MH, Madjar S, Ziadlourad F, Raz S. Life-threatening anaphylactoid reaction associated with indigo carmine intravenous injection. Urology. September 2000; 56(3): 508iii-iv. 46.Comiter CV, Vasavada SP, Barbaric ZL, Gousse AE, Raz S. Grading pelvic floor prolapse and pelvic floor relaxation using dynamic magnetic resonance imaging. Urology. September 1999; 54 (3): 454-7. 47.Safir MH, Gousse AE, Rovner ES, Ginsberg DA, Raz S. 4-Defect repair of grade 4 cystocele. J Urol. February 1999; 161: 587-594. 48.Safir M, Gousse A, Raz S. Bladder diverticula causing urinary reention in a woman without bladder outlet obstruction. J Urol. December 1998; 160: 2146-2147. 49.Safir M, Gousse A, Cederbaum S and Raz S. Voiding dysfunction in a mother and daughter with mitochondrial cytopathy. J Urol. September 1998; 160: 830. 50.Gosalbez R, Wei D, Gousse A, Castellan M and Labbie A. Refashioned short bowel segments for the construction of catheterizable channels (the Monti procedure): Early clinical experience. J Urol. September 1998; 160 (3 Pt 2): 1099-102. 51.Gousse A, Safir M H and Raz S. Tubulovillous adenoma in the cecal segment after cecocystoplasty: J Urol. August 1998; 160(2): 490-1. 52.Raz S, Gousse AE. The male bulbourethral sling procedure for post-radical prostatectomy incontinence. Editorial Comment; J Urol. May 1998; 159:1515. 53.Gosalbez R and Gousse A. Reconstruction and undiversion of the short or severely dilated ureter: The antireflux ileal nipple revisited. J Urol. February 1998; 159(2): 530-4. 54.Gousse A, Roth DR, Popek E J, Cooley L, Horowitz M E. Primary Ewings’ Sarcoma of the bladder associated with an elevated antinuclear antibody titer. J Urol. December 1997; 158(6): 2265-6. 55.Stapleton AM, Timme TL, Gousse AE, Li QF, Tobon AA, Kattan MW, Slawin KM, Wheeler TM, Scardino PT, Thompson TC. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. Clinical Cancer Research. August 1997; 1389-97. 56.Eastham J, Stapleton A, Gousse A, Slawin KM, Wheeler TM, Scardino PT, Thompson, TC. Association of p53 mutations with metastatic prostate cancer: Clin Cancer Res. October 1995; 1 (10): 1111-8. 57.Kamai T, Fukumoto Y, Gousse A, Yoshida M, Davenport AT, Weiss RM, Latifpour J. Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens. J Urol. September 1994; 152(3): 1017-21. 58.Latifpour J, Gousse A, Yoshida M, Weiss RM. Effect of insulin and dietary myoinositol on muscarinic receptor alterations in diabetic rat bladder. J Urol. March 1992; 147(3): 760-3. 59.Lewis Al, Li KB, Gousse A, Pereira F, Pacheo N, Pierre S, Kodman P and Lawson S. Genetic and molecular analysis of spontaneous respiratory deficient (res-) mutants of Escherichia coli K-12. Microbiol Immunol. 1991; 35 (4): 289-301. 60.Latifpour J, Gousse A, Yoshida M, Weiss RM. Muscarinic receptors in diabetic rat prostate. Biochemical Pharmacology. December 1991; 42 Suppl: S113-9. 61.Gousse A, Yoshida N, Weiss RM, Latifpour J. Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol. Prostate. 1991; 19(2): 121-31. 62.Latifpour J, Gousse A, Kondo S, Morita T, Weiss RM. Effects of experimental
diabetes on biochemical and functional characteristics of bladder muscarinic
receptors. J. Pharmacology and Experimental Therapeutics. January 1989; 248(1):
81-88.
19. Other Works, Publications & Abstracts:

Publications:
1. Angelo E Gousse, Diana Cardenas: Urology Domain, International Standards to Document Remaining Autonomic Function After Spinal Cord Injury. ASIA and ISCoS August 2006. 2. Angelo E. Gousse, Robert R. Kester, Patricia M. Byers: Complications in Surgery and Trauma. Informa Healthcare. 2006, Edited by Stephen M. Cohen (591)48. 3. Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade IV Cystocele Repair Using Four-Defect Repair and Porcine Xenograft Acellular Matrix (Pelvicol): Outcome Measures Using SEAPI. Journal of Urology. August 2004 4. Gousse AE, Leboeuf L. American Urologic Association “Issues in Incontinence”: Evaluation and Management of Severe Grade IV Cystocele. AUA 2003 Edition and Spring/Summer 2003 5. Gousse AE, Tiguert R, Madjar S. Current investigations and treatment for interstitial cystitis. Current Urology Reports 1(3): 190-8. September 2000. 6. Gousse AE, Stress urinary incontinence. WebMD.com: Medical Library Abstracts

Gousse AE, Kanagarajah P, Ayyathurai R, Caruso DJ: A single center, prospective,
randomized study to evaluate the effect of repeat intradetrusor injections of
Botulinum toxin-A for refractory Idiopathic overactive bladder patients. Podium
Presentation; Society for Urodynamics and Female Urology Annual Meeting,
Florida, USA, February 2010.
Caruso DJ, Kanagarajah P, Krasnow RE, Cohen BL, Gousse AE: What is the
Predictive Value of Urodynamics When Compared to Clinical History and
Validated Instruments? Podium Presentation; Society for Urodynamics and Female
Urology Annual Meeting, Florida, USA, February 2010.
Kanagarajah P, Caruso D, Gousse A: Severe bladder neck contracture and stress
urinary incontinence in patients status post prostatectomy, radiation and
cyrotherapy: Successful management using a two-staged approach. Moderated
Poster Presentation; International Continence Society Annual Meeting, San
Francisco, USA, October 2009.
Caruso D, Kanagarajah P, Gomez C, Gousse A: Is Abdominal straining seen on
urodynamics a normal variant of female voiding or an artifact? Poster Presentation;
International Continence Society Annual Meeting, San Francisco, USA, October
2009.
Caruso D, Kanagarajah P, Gousse A: 100 VS. 150 Units of intra-detrusor Botox: Dose differences in OAB-WET patients? Poster Presentation; International Continence Society Annual Meeting, San Francisco, USA, October 2009. Caruso D, Kanagarajah P, Gomez C, Gousse A: Artificial urinary sphincter (AMS 800) ™ Outcome in complicated prostate cancer patients. Poster Presentation; International Continence Society Annual Meeting, San Francisco, USA, October 2009. Gousse AE, Shirodkar S, Gomez C, Kanagarajah P, Barboglio P, Caruso DJ: Botox® for Idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of urodynamically demonstrable detrusor overactivity. Moderated Poster Presentation; Society for Urodynamics and Female Urology Annual Meeting, USA, February 2009. Caruso D, Gomez C, Kanagarajah P, Gousse A: Isolated posterior pelvic organ prolapse: What clinical or Urodynamic Findings drive patients to seek surgical correction? International Continence Society Annual Meeting, San Francisco, USA, October 2009. Gousse AE, Kanagarajah P, Ayyathurai R, Caruso DJ: A single center, prospective, randomized study to evaluate the effect of repeat intradetrusor injections of Botulinum Toxin-A for refractory idiopathic overactive bladder patients: Dose difference between 100U VS 150U. AUA Annual meeting, San Francisco, USA, May 2010. Submitted. Gousse AE, Barboglio PG, Cohen BL, Rodriguez D, Caruso DJ, The need for intermittent catheterization during repeated Botox injections for idiopathic OAB? ICS Annual Meeting- Poster Presentation; Cairo, Egypt; October 2008. Gousse AE, Barboglio PG, Cohen BL, Rodriguez D Caruso DJ. Can we predict who will respond to botulinum toxin-A injections for idiopathic overactive bladder? ICS- Poster Presentation; Cairo, Egypt; October 2008. Gousse AE, Barboglio PG, Cohen BL, Rodriguez D, Caruso DJ, Botox for idiopathic overactive bladder patient refractory to antimuscarinic therapy in the absence of detrusor overactivity. ICS Annual Meeting – Moderated podium Presentation; Cairo Egypt; October 2008. Gousse AE, Surgical Management of Urinary Incontinence and Pelvic Organ Prolapse in Women/POP .Association des Medecins Haitiens a l’Etranger-AMHE.July 2008. Gousse AE, Botulism Toxin Treatment of Bladder Dysfunction, benign Prostatic Hyperplasia/Voiding Dysfunction/Urologic Pelvic Pain. Moderated-NMA Urology Section; July 2008. Gousse AE, Winter CJ, SESAUA- Moderated Urodynamics Poster Presentation; San Diego, CA; March 2008. Gousse AE, Ginsberg DA, SUFU – Moderated Neurourology Podium Session Miami, Fl; February 2008. Gousse AE, Barboglio PG, Caruso DJ, Rodriguez D, Cohen B. 100 vs. 150 units of intra-detrusor Botox: Dose differences in OAB-dry patients? AUA National Meeting – Moderated Poster Presentation; Orlando, FL; May 2008. Barboglio PG, Cohen B, Caruso DJ, Gousse AE. Bladder outlet obstruction in women with isolated rectocele. AUA Moderated Poster Presentation; Orlando, FL; Gousse AE, Barboglio PG, Caruso DJ, Rodriguez D, Cohen B. The need for intermittent catheterization during repeated Botox injections for idiopathic OAB. Moderated Poster Presentation; Orlando, FL; May 2008. Angelo Gousse, Brian Cohen, Dinorah Rodriguez and Paholo Barboglio botulinum Toxin A 100 vs 150 Units in Idiopathic Overactive Bladder patients: Is there any difference? Oral Poster presentation at the ICS, Rotterdam, The Netherlands. 20 – 24 Aug 2007. Angelo Gousse, Brian Cohen, Dinorah Rodriguez and Paholo Barboglio botulinum Toxin A 100 vs 150 Units in Idiopathic Overactive Bladder patients: Is there any difference? Oral Poster presentation at the ICS, Rotterdam, The Netherlands. 20 – 24 Aug 2007. Angelo Gousse, Brian Cohen, Dinorah Rodriguez and Paholo Barboglio botulinum Toxin A 100 vs 150 Units in Idiopathic Overactive Bladder patients: Is there any difference? Oral Poster presentation at the ICS, Rotterdam, The Netherlands. 20 – 24 Aug 2007. Paholo Barboglio, Brian Cohen, Dinorah Rodriguez and Angelo Gousse what is the Predictive Value of Urodynamics when compared to Clinical History?Oral Poster presentation at the ICS, Rotterdam, The Netherlands. Top of Form Bottom of Form Paholo Barboglio, Brian Cohen, Dinorah Rodriguez and Angelo Gousse what is the Predictive Value of Urodynamics when compared to Clinical History?Oral Poster presentation at the ICS, Rotterdam, The Netherlands. 20 – 24 Aug 2007. Angelo E. Gousse, Brian Cohen, Dinorah Rodríguez and Paholo G Barboglio Correlation between voiding diary and the UDI-6 validated questionnaire in idiopathic OAB patients subjected to a Repeated Botox ™ Injection protocol. Accepted as a Podium at the AUA, Anaheim, CA. 19-24 May 2007. Paholo G Barboglio, Cohen Brian, and Angelo E. Gousse The Impact of Anterior
Pelvic Organ Prolapse on Female Sexual Function using validated instruments”
Accepted as a Podium at the AUA, Anaheim, CA. 19-24 May 2007.
Paholo G Barboglio, Cohen Brian, and Angelo E. Gousse The Urinary Distress
Inventory questionnaire (UDI-6) and Clinical Findings: Do they Correlate in our
Office?” Accepted as a Moderated-Poster at the AUA, Anaheim, CA. 19-24 May
2007
Frederick A. Klien, Angelo E Gousse, Urodynamics and Female Urology Poster
Session: Accepted as Moderated-Poster at the SESAUA, Lake Buena Vista, FL. 8-
11 Mar 2007.
Barboglio“Scheduled Repeated Botox™ Injections for Idiopathic OAB: Evaluating Therapeutic Time Accepted as Moderated-Posterat the AUA, Anaheim, CA. 19-24 May 2007, Mar 2007. Accepted as Moderated-Poster at the SUFU, San Diego, CA. 21- 24 Feb 2007. Paholo Barboglio, Cohen Brian, and Angelo E. Gousse “The Impact of Overactive Bladder (OAB) and Urinary Incontinence on Female Sexual Function using validated instruments”. Accepted as a Podium at the SUFU, San Diego, CA. 21-24 Feb 2007 Paholo E.Gousse“Detrusor overactivity and valsalva induced leakage on urodynamics in women with mixed, pure stress and pure urge urinary incontinence. Is there a difference? SUFU. Our Lucaya, Bahamas, Feb 22-2006. B. Cohen, R. Rivera, P.G. Barboglio and A.E. Gousse Urology, “Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botulinum toxin-A injection”. Vol. 68, Supplement 1, Nov 2006; Page 44. Presented as a Podium at the SIU, Cape Town, South Africa. 12-16 Nov 2006 P Barboglio, R. Rivera, H. Tunuguntla, L. Cason and A.E. Gousse Urology, “Repeat Botox A injections are safe and efficacious in neurogenic overactive patients: results of a single center prospective trial” American Urological Society Annual Meeting, Atlanta, GA. 20-25-May 2006 B. Cohen, R. Rivera, P.G. Barboglio and A.E. Gousse Urology,“Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botulinum toxin-A injection” Vol. 68, Supplement 1, Nov 2006; Page 44 Presented as a Podium at the SIU, Cape Town, South Africa. 12-16 Nov 2006 R. Rivera, P. Barboglio, M. Hellinger and A. Gousse Urology,”Outcomeanalysis following surgery for female urethral diverticula using validate instruments. Vol. 68, Supplement 1, Nov 2006; Page 165 Presented as Moderated-Poster at the SIU, Cape Town, South Africa. 12-16 Nov 2006 Gousse A, Tununguntla, Bateman D, Velasquez D. Dose-Finding prospective randomized study to evaluate the efficacy and safety of Boutlinum-A toxin for Refractory Non-Neurogenic Overactive Bladder. SUFU/ISPiN Annual Meeting February 2005 ( Neurourology Urodynamics; Vol. 24, No. 2, 2005) Gousse A, Tunuguntla H. Two stage management of anastomotic contracture and stress urinary incontinence following radical prostatectomy. 27th Congress of the Societe International d’Urology, Honolulu, HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October 2004) GousseA, Tununguntla H, Leboeuf L Can we predict response to test stimulation during the first stage interstim sacral neuromodulation? 27th Congress of the Societe International d’Urology, Honolulu, HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October 2004) Tunuguntla HSGR, Leboeuf L, and Gousse AE. Bladder Capacity in interstitial cystitis: differences between cystometry and hydrodistention under anesthesia 27th Congress of the Societe International d’Urology, Honolulu, HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October 2004) GousseA, Tununguntla H, Leboeuf L. Efficacy and safety of sacral neuromodulation in dysfunctional voiding of variable etiology. 27th Congress of the Societe International d’Urology, Honolulu, HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October 2004) GousseA, Tununguntla H, Leboeuf L, Bateman D and Velazquez D.Intravesical Botulinum–a Toxin Therapy for refractory overactive bladder; early results. 27th Congress of the Societe International d’Urology, Honolulu,HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October, 2004). Gousse A, Leboeuf L, Tunuguntla H, Hellinger M. Surgical management of rectourinal fistula. Are the anteriar rectal flaps reliable. 27th Congress of the Society International d’Urology, Honolulu, HI (USA) October 2004 (British Journal of Urology; Vol. 94, Supp 2, October 2004) Leboeuf L, Mile RA, Kim SS, Gousse AE. Vaginal repair of severe cystocele with porcine xenograft matrix (Pelvicol™) combined with tension-free vaginal tape (TVT). International Continence Society Annual Meeting, Florence, Italy. October 2003. Leboeuf L, Mile RA, Kim SS, Gousse AE. Pelvicol®: initial results of a xenograft implant in pelvic floor reconstruction. International Continence Society Annual Meeting, Florence, Italy. October 2003. Leboeuf L, Miles RA, Kim SS, Gousse AE. Bladder capacity in interstitial cystitis: differences between awake cystometry and hydrodistension under anesthesia. International Continence Society Annual Meeting, Florence, Italy. October 2003. Gousse AE, Leboeuf L, Hellinger M. Surgical management of urinary incontinence associated with rectovesical fistulas: the transanal rectal flap approach (video presentation). International Continence Society Annual Meeting, Florence, Italy. October 2003. Gousse AE, Razdan S, Schroeder GL, Kester RR, Lokeshwar V. Nerve growth factor levels in diabetic rat bladder: Effects of cystostomy creation on previous observations. American Urological Society Annual Meeting, Chicago, IL. April 2003. Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade IV cystocele repair using four-defect repair and porcine xenograft acellular matrix (Pelvicol®): outcome measures using SEAPI. American Urological Society Annual Meeting, Chicago, IL. April 2003. Leboeuf L, Gousse AE. Female sexuality: from hysteria to female sexual dysfunction. American Urological Society Annual Meeting, Chicago, IL. April 2003. Gousse AE, Razdan S, Schroeder GL, Kester RR, Lokeshwar V. Nerve growth factor levels in diabetic rat bladder: Effects of cystostomy creation on previous observations. Society for Urodynamics and Female Urology Annual Meeting, Chicago, IL. April 2003. Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade IV cystocele repair using four-defect repair and porcine xenograft acellular matrix (Pelvicol®): outcome measures using SEAPI. Society for Urodynamics and Female Urology Annual Meeting, Chicago, IL. April 2003. Lorenzo-Gomez F, Schroeder GL, Kester RR, Gousse AE, Lokeshwar VB. Correlation of urinary glycosaminoglycan levels and profile with disease severity in interstitial cystitis patients. European Association of Urology Congress, Madrid, Spain. March 2003. Kester R, Kim S, Benoit A, Amendola M, Gousse AE. The value of express T2-weighted pelvic MRI in the preoperative evaluation of severe pelvic floor prolapse: a prospective study. International Continence Society 2002 Meeting. Heidelberg, Germany. August 29, 2002. Kester R, Soloway C, Kava B, Kim S, Gousse AE. Association between urinary incontinence and female sexual dysfunction: a preliminary, prospective study using validated questionnaires. International Continence Society 2002 Meeting. Heidelberg, Germany. August 2002. Gousse AE, Kester R, Raz S. Anterior vaginal wall sling long-term outcome data: differences between office versus postal surveys. International Continence Society 2002 Meeting. Heidelberg, Germany. August 2002. Gousse AE, Kester R, Schroeder G, Selzer M, Gibson X, Lokeshwar V. Correlation of urinary glycosaminoglycan levels and profile with disease severity in interstitial cystitis patients. International Continence Society 2002 Meeting. Heidelberg, Germany. August 29, 2002. Lokeshwar VB, Schroeder GL, Gibson XA, Selzer MG, Kester RR, Gousse AE. Correlation of urinary glycosaminoglycan levels and profile with disease severity in interstitial cystitis patients. Annual Society for Urodynamics and Female Urology Meeting. Orlando, Florida; May 25, 2002. Razdan S, Gousse AE. Schafer nomogram characterizes bladder outlet obstruction in women with severe grade 4 cystocele. 97th Annual Meeting of American Urological Association. Orlando, Florida; May 27, 2002. Lokeshwar VB, Schroeder GL, Gibson XA, Selzer MG, Kester RR, Gousse AE. Correlation of urinary glycosaminoglycan levels and profile with disease severity in interstitial cystitis patients. 97th Annual Meeting of American Urological Association. Orlando, Florida; May 26, 2002. Kester RR, Williams RJ, Gousse AE. Prostate specific antigen values in spinal cord injured patients. American Spinal Injury Association & International Medical Society of Paraplegia 1st Joint Meeting - Vancouver, Canada. May 3 – 6, 2002. Alavi A, Kester RR, Madjar S, Meinbach DS, Weinstein D, Gousse AE. Effect of long-term bladder management on videourodynamic parameters in spinal cord injured patients. American Spinal Injury Association & International Medical Society of Paraplegia 1st Joint Meeting - Vancouver, Canada. May 3 – 6, 2002. Kester RR, Alavi A, Madjar S, Meinbach DS, Weinstein D, Gousse AE. Correlation of level of spinal cord injury with presence of renal dysfunction. American Spinal Injury Association & International Medical Society of Paraplegia 1st Joint Meeting - Vancouver, Canada. May 3 – 6, 2002. Madjar S, Balzarro M, Nelson D, Gousse AE. Pain characteristics in female interstitial cystitis patients: is there a common pattern? International Continence Society 31st Annual Meeting – Seoul, Korea; September 2001. Gousse AE, Madjar S, Alavi A. Two-stage management of anastomic contracture and stress urinary incontinence following radical prostatectomy. International Continence Society 31st Annual Meeting – Seoul, Korea; September 2001. Gousse AE, Razdan S. Schafer nomogram to characterize bladder outlet obstruction in women with severe grade IV cystocele. International Continence Society 31st Annual Meeting – Seoul, Korea; September 2001. Evans DH, Meinbach DS, Madjar S, Gousse AE. Female anti-incontinence procedures: practice patterns in Florida, USA. International Continence Society 31st Annual Meeting – Seoul, Korea; September 2001. Meinbach DS, Alavi AS, Madjar S, Razdan S, Sipski M, Weinstein D, Gousse AE. Renal nuclear scan or renal sonogram for surveillance of spinal cord injured patients. American Paraplegia Society 47th Annual Meeting - Las Vegas, Nevada; September 2001. Madjar S, Evans D, Gousse AE. Collaboration and practice patterns among urologists and gynecologists in the treatment of urinary incontinence and pelvic floor prolapse: A survey of the International Continence Society Members. National Medical Association 2001 Annual Convention & Scientific Assembly. Nashville, TN; August 6, 2001. Madjar S, Nelson D, Gousse AE. Sexual dysfunction among female interstitial cystitis patients: a case-controlled study. Society for Urodynamics and Female Urology Annual Meeting - Anaheim, California; June 2001. Meinbach DS, Alavi AS, Madjar S, Razdan S, Sipski M, Weinstein D, Gousse AE. Renal scan or renal sonogram: which is the most appropriate upper tract study in the urologic surveillance of spinal cord injured patients? 96th Annual Meeting of the American Urological Association - Anaheim, California; June 2001. Evans DH, Gousse AE. From American slaves to laparoscopic surgery: the long and winding historical road of vesicovaginal fistula repairs. 96th Annual Meeting of the American Urological Association - Anaheim, California; June 2001. Razdan S, Meinbach DS, Sipski M, Weinstein D, Gousse AE. Current practice patterns in urologic management of SCI patients. American Spinal Injury Association 27th Annual Scientific Meeting - Long Beach, California; May 2001. Meinbach DS, Alavi AS, Madjar S, Razdan S, Sipski M, Weinstein D,Gousse AE. Renal scan vs. ultrasound: which is most appropriate for urologic surveillance? American Spinal Injury Association 27th Annual Scientific Meeting - Long Beach, California; May 2001. Meinbach DS, Alavi AS, Madjar S, Razdan S, Sipski M, Weinstein D, Gousse AE. Renal scan or renal US: which is the most appropriate upper tract study in the urologic surveillance of spinal cord injured patients? Southeastern Section of the AUA 65th Annual Meeting - New Orleans, Louisiana; April, 2001. Razdan S, Meinbach DS, Sipski M, Weinstein D, Gousse AE. Current practice patterns in the urologic management of spinal cord injured patients. Southeastern Section of the AUA 65th Annual Meeting - New Orleans, Louisiana; April, 2001. Evans DH, Madjar S, Meinbach DS, Gousse AE. Female anti-incontinence procedures: practice patterns in Florida. Southeastern Section of the AUA 65th Annual Meeting - New Orleans, Louisiana; April, 2001. Madjar S, Evans D, Gousse AE. Differences among urologists and gynecologists who treat urinary incontinence and pelvic floor prolapse. 25th Congress of the Société Internationale d’Urologie – Singapore; October 2000. Gousse AE, Madjar S, Weinstein D. Variability of positive fluoroscopic findings among men with voiding dysfunction undergoing video-urodynamic evaluation. 25th Congress of the Société Internationale d’Urologie – Singapore; October 2000. Gousse AE, Madjar S, Amendola M. “Express” MRI sequence in the evaluation of female pelvic pathology: A rapid comprehensive non-invasive approach. 25th Congress of the Société Internationale d’Urologie - Singapore; October 2000. Madjar S, Evans D, Duncan RC, Gousse AE. Collaboration between urologists and gynecologists in the treatment of urinary incontinence and pelvic floor prolapse. 25th Congress of the Société Internationale d’Urologie - Singapore; October 2000. Madjar S, Gousse AE, Lambert M, Fishman IJ. Artificial urinary sphincter implantation for post-radical prostatectomy urinary incontinence: which factors influence patients satisfaction? 25th Congress of the Société Internationale d’Urologie – Singapore; October 2000. Madjar S, Evans D, Duncan RC, Gousse AE. Collaboration between urologists and gynecologists in the treatment of urinary incontinence and pelvic floor prolapse. International Continence Society Annual Meeting - Tampere, Finland; August 2000. Madjar S, Gousse AE, Lambert M, Fishman IJ. Artificial urinary sphincter implantation for post-radical prostatectomy urinary incontinence: which factors influence patients satisfaction? International Continence Society Annual Meeting - Tampere, Finland; August 2000. Madjar S, Evans D, Gousse AE. Differences among urologists and gynecologists who treat urinary incontinence and pelvic floor prolapse. International Continence Society Annual Meeting - Tampere, Finland; August 2000. Gousse AE, Madjar S, Weinstein D. Variability of positive fluoroscopic findings among men with voiding dysfunction undergoing video-urodynamic evaluation. Southeastern Section American Urological Association Meeting - Orlando, Florida; April 2000. Evans D, Madjar S, Politano V, Bejany D, Lynne C, Gousse AE. Are interposition grafts necessary in transabdominal vesicovaginal fistula repairs? XVth Congress of the European Association of Urology - Brussels, Belgium; April 2000. Gousse AE, Madjar S. Passive bulbar urethral compression for the treatment of post-prostatectomy incontinence. Is history repeating itself? 95th Annual Meeting of the American Urological Association - Atlanta, Georgia; April 2000. Gousse AE, Madjar S, Amendola M. “Express” MRI sequence in the evaluation of female pelvic pathology: a rapid comprehensive non-invasive approach. 95th Annual Meeting of the American Urological Association - Atlanta, Georgia; April 2000. Barbaric ZL, Gousse AE, Marumoto AK, Sinha S, Raz S. Pelvic floor descent and prolapse: Grading system using MRI. American Roentgen Ray Society Meeting - New Orleans; May 1999. Marumoto AK, Barbaric ZL, Gousse AE, Raz S. Pelvic floor prolapse and relaxation: economical evaluation with HASTE and SSFSE MRI. 84th Scientific Assembly of Radiological Society of North America. CUM LAUDE AWARD. January 1999. Barbaric L, Gousse AE, Marumoto AK, Sinha S, Raz S. Pelvic floor descent and prolapse: grading system using MRI. Closed scientific session of European Society of GU Radiology – Strasbourg; September 1998. Blake P, Carrion R, Politano V, Gousse AE. Transurethral injectables in the treatment of male and female urinary incontinence: Long-term outcome results. Southeastern Section of AUA Meeting - Naples, Florida; 1997 Gousse AE, Labbie A, and Gosalbez R. Reconstruction and undiversion of the short or severely dilated ureter: The antireflux ileal nipple revisited. Urology Section American Academy of Pediatrics Meeting - Boston, Massachussets; November 1996 Gousse AE, Lambert M, Fishman Artificial urinary sphincter for the treatment of post radical prostatectomy urinary incontinence: Long term outcome results I. J Urol 155: 456A. AUA Meeting – Orlando, Florida; 1996. Gousse AE, Tobon AA, Eastham JA, Slawin KM, Wheeler TM, Scardino PT, Thompson TC. Clonal expansion of p53 mutations at metastatic sites in clinical prostate cancer: An analysis using TA-SSCP. J Urol 153: 471A, 1995. AUA Meeting – Las Vegas, Nevada; 1995 Gousse AE, Coburn M. Penile injuries: A ten year review. J Urol 151: 307A. AUA Meeting – San Francisco, CA. 1994 Gousse AE, Slawin KM, Wheeler TM, Scardino PT, Thompson TC. A novel approach for detecting p53 mutations in heterogeneous prostate tissue samples using TA-Cloning-PCR-SSCP. J Urol 151:471A. AUA Meeting – San Francisco, CA. 1994 Lewis LA, Gousse AE, Pereira B, Li K. Genetic basis of induced aminoglycoside-resistant variant in E. coli and Staphylococcus aureus. Genetics 113:s75, 1986 Student National Medical Association - Miami, Florida.
20. Other Works Accepted for Publication:

1. The Journal of Urology (in press July 2005)
2. Madjar S, Hollowell CP, Tiguert R, Gousse AE. Endoscopically guided removal of difficult to manage retained bladder sutures. Techniques in Urology (in - press).
PROFESSIONAL

21. Funded Research: Current
A 12 week,randomised, double blind, placebo controlled, parallel group, multicenter trial to evaluate the efficacy and safety of Fesoterodine in patients with symptoms of overactive bladder including nocturnal urinary Pfizer PI
A phase 3, randomized, double-blind, parallel group, placebo controlled, multicenter study to assess the efficacy and safety of Beta 3 agonist YM-178 Astellas PI
(25mg and 50mg qd) in subjects with overactive bladder symptoms. A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by Treatment with BOTOX® in Patients with Urinary Allergan PI
Incontinence Due to Neurogenic Detrusor Overactivity A Multicenter, Long-term Follow-up Study of the Safety and Efficacy of Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Urinary Incontinence Due to Allergan PI
Botulinum-A toxin injection for overactive bladder: A non-surgical Allergan PI
approach.(Dr.Gousse) A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RESPONSE STUDY OF THE SAFETY AND EFFICACY OF A SINGLE TREATMENT OF BOTOX® (BOTULINUM TOXIN TYPE A) PURIFIED NEUROTOXIN COMPLEX IN PATIENTS WITH IDIOPATHIC OVERACTIVE Allergan PI
Allergan PI
Botox injections for Idiopathic overactive bladder patients. A Placebo-Controlled, Randomized, Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Neurogenic Detrusor Overactivity and Neurological Allergan PI


8/04- present Kava, Bruce R., MD [4836.01] A Randomized Trial
Comparing a Transverse Incision with the Traditional Longitudinal Incision in Men Undergoing a Radical Prostatectomy Co-Investigators: Gousse, Angelo E., M.D. Controlled Parallel-Group Study of the Safety and Efficacy of Repeat Treatment with Two Dose Levels of Botox (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with Botox in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Angelo Gousse, MD Principal Investigator Sponsor: Allergan Total Direct Funds: $394,883 Total Award $498,95 Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach Allergan Total Award $50,000 A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Dose-ResponseStudy of the Safety and Efficacy of a Single Treatment of Botox (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Urge Incontinence Angelo Gousse, MD Principal Investigator Sponsor: Allergan Total Direct Funds: $311,240 Total Award $389,05 04/05-03/07 Evaluation of Patients Who Have Completed More Than 180 Days Of Active Treatment with Ro115-124NN18191 Hoffman-La Roche Total Award $ 14,468 Botulinum Toxin Type A Injection for Overactive Bladder: A Non-Surgical Approach Angelo Gousse, MD Principal Investigator Sponor:Allergan total Direct Funds: $256,000 An Open-Label Extension for Treatment of Incontinent Patients who have completed an Ro115-1240 study NN16586 Hoffman-La Roche Total Award $ 57,425 PI: Gousse, Angelo E., M.D. Protocol No.: [3216.01] Title: Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach Co-Investigators: Gomez-Marin, Orlando, Ph.D. Tunguntla, Hari, M.D. Research Coordinators: Cason, Lottie, BS. Jacobs, Patrick L., Ph.D. [7927.04 [B2656C]] Center of Excellence in Functional Recovery in Chronic Spinal Cord Injury Co-Investigators: Alexander, Craig, Ph.D. Banovac, Kresimir Gousse, Angelo E., M.D Principal Investigator. Funded by the Miami Veterans Affairs Hospital/Center for Excellence in Functional Recovery in Chronic Spinal Cord Injury: Botulinum-A toxin injection for detrusor hyperreflexia in SCI: A non surgical approach. ($74,000.00) 10/03-12/04 Safety and effectiveness of Duloxetine in women with symptoms mixedurinary incontinence. Eli Lilly Total Award $115,446 Principal Investigator.Funded by MERCK: Rofecoxib for Postoperative Analgesia After Pelvic Floor Reconstruction Surgery. ($30,000.00) Principal Investigator. Funded by Roche: Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Effects of a Partial Alpha 1A/1L-adrenoceptor Agonist, Ro115-1240, in Women with Stress Urinary Incontinence and Mixed Urinary Incontinence. ($150,000.00 for 20 patients) Principal Investigator. Funded by Allergan: BOTOX – Intravesical Injection in the Management of Refractory Overactive Bladder. ($ 100,000.00) Co-Investigator. Funded by the Fishbein Family Interstitial Cystitis Research Grant: Elevated urinary total/sulfated glycosaminoglycan ratio: A cause or effect of interstitial cystitis. ($28,503.00) Principal Investigator. Kidney Foundation of South Florida: The role of frequent micturition in diabetic rat bladder hypertrophy. A study of insulin-like growth factor binding protein expression. ($4,000.00) Co-Investigator. University of Miami School of Medicine: Instrument Grant. ($13,647.00) Co-Investigator. Kidney Foundation of South Florida: Laparoscopic assisted two-stage ureterocystoplasty with preservation of the renal units: a pig model. ($4,000.00) PI- Penile Vibratory 22. Editorial Responsibilities:

Section Editor- Current Urology Reports ( Female Urology) - 2007-current
• Reviewer for the Society For Urodynamics & Female Urology. 2000– • Reviewer for the Journal Of Urology. 2001 – present. • Reviewer for the Journal Of Rehabilitation Research and Development. • Reviewer for Urology- Gold Journal- 2001 – present. • Reviewer for NeuroUrology Urodynamics-2002-present • Reviewer for the British Journal of Urology-2007-present.
23. Professional and Honorary Organizations:
• American Urological Association: Active Member • Southeastern Section, American Urological Association: Active Member • Society for Urodynamics & Female Urology: Active Member • Society of University Urologists: Active Member • Florida Urological Society: Active Member • American Spinal Injury Association: Urology Committee Officer and • International Continence Society Active Member • European Association of Urology: Corresponding Member • Haitian Association of Physicians Abroad (AMHE) • Society of Genitourinary Reconstructive Surgeons- Active Member 24. Honors and Awards:
• Best Doctors in America 2008-2009
• University of Miami School of Medicine

Non-Institutional:
• Pfizer Scholars in Urology – July 1999 Institutional Residency:
• Cullen Award [Outstanding Research by a Resident], Scott Department of • Harry M. Spence Award [Resident Essay First Prize], Texas Urological • American Federation Urologic Disease (AFUD) Scholarship Awarded Institutional Medical School:
• Cum Laude [Highest Yale Medical School Academic Distinction • Cortandt-Van Rensselaer Creed [Sigma Pi Phi], M.D. Cum Laude Award
Institutional College:
• Valedictorian, City University of New York (CUNY), York College June • Phi Beta Kappa (Honor Society) June 1986 • Dr. Jonas E. Salk Scholarship [Outstanding Research Potential], CUNY • Sigma Xi [Scholarly Research] June 1986 • Honors in Biology – CUNY York College
25. Post-Doctoral Fellowships:

• Fellowship in Urodynamics, Female Urology, and Pelvic Floor Reconstruction. University of California Los Angeles. July 1997 – June 1998 • Fellowship in Urodynamics & Reconstruction. University of Miami Department of Urology. July 1996 – June 1997
26. Other Professional Activities:

Invited Lectures:
1. State of the Art lecture; Instabilite Vesicale Rebelle: de Nouveaux
Algorithmes Therapeutiques French Urologic Association 100 th
Anniversary Meeting- Paris, France ,Novermber 30, 2006.
2. State of the Art Lecture; Simultaneous vs Bladder Neck Incision and
Incontinence Surgery; Genitourinary Reconstructive Surgeons (GURS) Association Meeting AUA 2007 Anaheim, CA. 3- Columbian Urologic Association- Visiting Professor- 1- Botulinum Toxin for Overactive Bladder Management 2- Pelvic Organ Prolapse Repair Using Synthetic Mesh , Medellin, Columbia 2008 4- Indian Urologic Association Lecture- Interstim Scaral Nerve Modulation versus Botulinum Toxin For Idiopathic Overactive Bladder American Urologic Association Meeting (AUA) , Chicago Illinois, 2009 1. 2007 Florida Urological Society Meeting. Aug 30th – Sept 2nd Miami FL. The Role of Botulinum Toxin in the Management of OAB. (Invited Speaker) 2. 2007 Florida Urological Society Meeting. Aug 30th – Sept 2nd Miami FL. Pitfalls in Urodynamic Testing: Extraneous Influences on Results. (Invited Speaker ) 3. 2007 Society of Genitourinary Reconstructive Surgeons Meeting. 17th May Anaheim CA. Invited Speaker. Simultaneous versus delayed bladder neck incision and incontinence surgery
4. Sixth Annual Wellness Plan for the Total Man: The benefits of regular
prostate cancer screenings for Afican-American men. Key Note Speaker, behalf of the Florida Department of Health office of Minority Health and Access Health Solutions April 2006. 5. 100th Congres Francais D’Urologie Conference, 29 November-2 December 2006. Chirurgie du prolapsus: resultants (Moderator). 6. 10th Minas Gerais Urology Conference (X Congresso Mineiro de Urologia), Ouro Preto, Brazil, June 2005 Brazil Courses/lectures x 5-6,
2005
7. Stress Urinary Incontinence: What Every Health Practitioner Should Know. Pri-Med Stress Urinary Incontinence Educational Series; May, September, November, and December 2004 Atlanta, Ga. 8. State of the Art Management of Overactive Bladder. Florida Academy of Physician Assistants. Altamonte Springs, Fl. August 2004 9. Clinical Lessons in Urology. Miami Dade Community College Medical
Campus Class Lecture. Miami, FL. July 2004 10. Duloxetine Urinary Incontinence Scientific Advisory Board. Eli Lilly and Company and Boehringer Ingelheim Educational Lecture. Tempe, Az. April, 2004 11. Managing Sexual Health in Men and Women. 5th Annual National CME Dinner Meeting of the University of North Carolina at Chapel Hill and the National Foundation for Sexual Health Medicine (NFSHM). Miami, FL. October 2003. 12. Female Sexual Circuitry: Sexual Response and Dysfunction. Boston University School of Medicine and National Foundation for Sexual Health Medicine’s Sexual Health Symposia. Miami, FL. September 2003 13. Lecture on Overactive Bladder. Dade County Medical Association Women’s Health Symposium. Miami, FL. September 2003. 14. Erectile Dysfunction. Association of Haitian Physicians Abroad 30th Annual Convention. Ottawa, Québec. July 2003. 15. Managing Sexual Health in Men. University of North Carolina School of Medicine and National Foundation for Sexual Health Medicine. Miami, FL. November 2002. 16. Tension-free Vaginal Tape for Stress Urinary Incontinence: Considering the Pros and Cons. Baptist Health South Florida Urology Conference (CME sponsored). Miami FL. November 2002. 17. State of the Art Management of Urinary Incontinence. Association of Haitian Physicians Abroad, South Florida Chapter. Miami FL. April 2002. Medicine/National Foundation for Sexual Health Medicine: Sexual Health School. Miami, FL March 2002. 19. Pharmacological Management of Urinary Incontinence. Baptist Hospital OB/GYN Conference. Miami FL. March 2002. 20. Etiology and differential diagnosis of overactive bladder. New Directions in the Management of the Overactive Bladder Medical Education Activity sponsored by Baylor College of Medicine and ALZA Pharmaceuticals. Rochester, NY. August 2001. 21. Management of Adenocarcinoma of the Prostate. Association of Haitian Physicians Abroad 27th Annual Convention. Fort Lauderdale, FL. July 2000. 22. Difficult Problems in Urology: Interstitial Cystitis. 2000 Florida Urological Society Annual Meeting. St. Petersburg, FL. September 2000. 23. Urinary Fistulas: Vesico-Vaginal Fistulas. 2000 Florida Urological Society Annual Meeting. St. Petersburg, FL. September 2000. 24. Neuromodulation/Biofeedback: How to Treat Urge Incontinence When Anticholinergics Fail. Florida Urological Society Annual Meeting. Aventura, FL. September 1999. 25. Implantes Neuroprotesicos Para el Tratamiento de la Incontinencia. Brazilian Journalists Conference. Cedars Medical Center/International Services. Miami, FL. August 1999. 26. Epidemiology of Prostate Cancer in African-American Men and P53 Clonal Expansion in Prostate Cancer. Minority Biomedical Research Support Science Seminar Series. York College, Jamaica, NY. April 1999. 27. Urinary Incontinence. Fifth Annual Nursing Advanced Practice Council
Panelist in Conference:

• Annual Society for Urodynamics and Female Uroloy, Urinary Frequency and Urge Urinary Incontinence in Botox Repeated Injections: Outcome data using voiding diaries and UDI-6 Correlation. (Moderated Poster) San Diego, CA.21-24 Feb 2007. • Allergan BOTOX® Advisory Board Panel Meeting: Overactive Bladder Disorders -Science and Clinical Practice (Panel Member). Budapest, Turkey. February 2005 • Annual Society for Urodynamics and Female Urology: (Podium Moderator). • Challenging Cases in Urology 15th Annual International Conference: Female Urology & Incontinence (Chair). Miami, Florida. February 2005. • Society International d’Urologie: Abstract Presenter (5 total). Honolulu, • Annual Society for Urodynamics and Female Urology: First Annual Freestanding Meeting (Podium Moderator). Scottsdale, Arizona. February 2004 • Challenging Cases in Urology 14th Annual International Conference: Female Urology & Incontinence (Chair). Miami, Florida. February 2004. • Allergan BOTOX® Advisory Board Panel Meeting: Overactive Bladder Disorders - Science and Clinical Practice (Panel Member). London, England. February 2004 • American Society of Spinal Injury Association Annual Meeting: Urology Papers. (Moderator). Miami, Florida. April 2003 • Challenging Cases in Urology 13th Annual International Conference: Female Urology & Incontinence (Chair). Miami, Florida. February 2003. • Annual Society for Urodynamics and Female Urology Meeting/Urological Gladiatorial Debates: Failed Collagen – Pubovaginal Sling vs. Durasphere. Orlando, Florida. May 2002. • Challenging Cases in Urology 12th Annual International Conference: Female Urology & Incontinence (Chair). Miami, Florida. February 2002. • UCLA Shlomo Raz Day: Female Stress Urinary Incontinence (Moderator). • UCLA Shlomo Raz Day: History of Post-Prostatectomy Urinary Incontinence Treatment (Panelist): a Tribute to Drs. Kaufman and Raz. Los Angeles, California. February 2001. • UCLA Shlomo Raz Day: My New Anti-Incontinence Procedure Du Jour: The Metallic Urethral Zipper Glued to an Obstructive Mesh Tape Technique (Panelist). Los Angeles, California. February 2001. • UCLA Shlomo Raz Day: MRI to Evaluate the Female Pelvis (Evaluation). • Challenging Cases In Urology 11th Annual International Conference: Female Urology & Reconstructive Surgery (Chair). Orlando, Florida. February 2001. • Paralyzed Veterans Year 2000 Urodynamics Meeting: Urodynamic Evaluation of Female Urge Incontinence. Miami, Florida. March 2000. • Challenging Cases In Urology 10th Annual International Conference: Voiding Dysfunction (Chair). Miami, Florida. February 2000. • Challenging Cases In Urology 9th Annual International Conference: BPH/Voiding Dysfunction (Chair). Miami, Florida. February 1999. • Challenging Cases In Urology 8th Annual International Conference: Female Urology (Chair). Miami, Florida. February 1998. • Challenging Cases In Urology 7th Annual International Conference: Incontinence and Reconstruction (Panelist). Miami, Florida. February 1997. • Instructor in Course:
Postgraduate Course: Adult Neurogenic Bladder: From Basics to Advanced Management. (Co-Instructor with Dr.Jacques Corcos, (Course #32 PG). American Urologic Association Meeting. Chicago Illinois, 2009 Postgraduate Course: Adult Neurogenic Bladder: From Basics to Advanced Management. (Co-Instructor with Dr.Jacques Corcos, (Course #32 PG). American Urologic Association Meeting. Orlando, Florida , 2008 • Lectures in Urology: Miami Dade Community College. Miami, Fl, July, • Surgical Problems and Procedures Urologic Surgery: Miami Dade Community College. Miami, Fl, July, 2004 • Voiding Dysfunction: An Overview. Mechanisms of Disease Course (for 2nd year medical students). University of Miami School of Medicine. Miami, FL September 2002. • Erectile Dysfunction: An overview. Mechanisms of Disease Course (for 2nd year medical students). University of Miami School of Medicine. Miami, FL September 2002. • Updates in the Management of the Neurogenic Bladder: Surveillance Protocols in Spinal Cord Injury Patients. Spinal Injury Association and International Medical Society of Paraplegia 1st Joint Meeting. Vancouver, Canada. May 3 – 6, 2002. • Incontinence & Voiding Dysfunction. Mechanisms of Disease Course (for 2nd year medical students). University of Miami School of Medicine. Miami, FL February 2002. • Evaluation of Urologic Disease. University of Miami School of Medicine Sophomore Clinical Skills Program lecture series. University of Miami School of Medicine. Miami, FL April 2001. • Incontinence & Voiding Dysfunction. Mechanism of Disease Course (for 2nd year medical students). University of Miami School of Medicine. Miami, FL April 2001. • Postgraduate Course: Vaginal Reconstructive Surgery. (Co-Instructor with Dr. Shlomo Raz, Course # 009865). American Urologic Association Meeting. San Diego, California 1998.
TEACHING

27. Teaching Awards Received:

• “2006-2007 Attending of the Year Award”: awarded by the chief residents
for excellent mentoring and above all for being an excellent residents advocate. University of Miami Department of Urology. • Finalist: 2003 ACGME’s Parker J. Palmer “Courage to Teach” Award. Nominated by the Accreditation Council for Graduate Medical Education (ACGME) for continuing to “…inspire generations of residents with the courage to teach”. • “2002-2003 Attending of the Year Award”: awarded by the chief residents for excellent mentoring and above all for being an excellent residents advocate. University of Miami Department of Urology. • “2001-2002 Distinguished Teaching Award”: awarded by the chief residents -Recognition for excellent mentoring and teaching. University of Miami Department of Urology. • “1999-2000 Attending of the Year Award of Excellence”: awarded by the chief residents for outstanding dedication and commitment to patients, colleagues and residents. University of Miami Department of Urology.
28. Teaching Specialization:
• Urology Residents: University of Miami Department of Urology. 08/98 to • Instructor: Tension-free Vaginal Tape (TVT) for the treatment of stress urinary incontinence. University of Miami UBERC (Metro Zoo). March 9, 2002. Cadaver Course sponsored by GYNECARE • Instructor: Tension-free Vaginal Tape (TVT) for the treatment of stress urinary incontinence. Orlando, FL. May 10, 2002. Cadaver Course sponsored by GYNECARE • Instructor: Tension-free Vaginal Tape (TVT) for the treatment of stress urinary incontinence. University of Miami UBERC (Metro Zoo). June 14, 2002. Cadaver Course sponsored by GYNECARE
29. Thesis and Dissertation Advising/Post-Doctoral Student Supervision:
Fellowship Director: Female Urology, Urodynamics, & Reconstructive Surgery. University of Miami Department of Urology:
SERVICE

30. University Committee and Administrative Responsibilities:
Urology Residency Program Director: Department of Urology Residency Program. October 2002 to present. Assistant Residency Program Director: Department of Urology Residency Program. July 1999 to 2002. Medical Students Recruitment and Advisor: LCME Self-Study Committee on Minorities and Women. March 2001 to present. Mentor: Minority Students Health Careers Motivation Program. April 2001 to present. Infection Surveillance & Policy Committee: Cedars Medical Center. Year 2000 to present. Medical School Library Committee 2003- present Admissions Committeee of Medical School – 2005-present 31. Community Activities:
• Haitian American Leadership Organization (HALO): President and Co-Founder

• Center for Haitian Studies: Board Member

• Angelo E. Gousse, M.D. and Alfred Brandon, M.D. Prostate Cancer Awareness Day: free prostate screening. Sponsored by Cedars Medical Center. February 12, 2000. • Radio Rico-Perez: Urinary Incontinence: Considering the Alternatives (In • Angelo E. Gousse, and Cedars Medical Center Prostate Cancer Awareness Day: free prostate screening. Sponsored by Cedars Medical Center. June 16, 2001. • Radio Carnival: Prostate Cancer Awareness • Prohealth Resources: Editorial Board

• Urologic Consultation in Creole Community Radio Show – Weekly
Radio Show (1580 AM and 1700 AM) - 2007-current

Source: http://bladder-health.net/images/Gousse_CV.pdf